Current/ Expected Orderbook/ Pending Orders?

As per the transcript, Medi Assist Healthcare Services Limited disclosed a contract liability of INR 280.2 crores as of March 31, 2026. This contract liability represents revenue that is committed but has not yet been recognized in the Profit & Loss statement. The contract liability can be understood as the current order book or pending revenue from signed contracts that will be recognized in future periods. The company indicated that a significant portion of revenue is recognized on a 12-month service basis, contributing to this contract liability. There is no explicit disclosure of new pendi

Any current/future new fundraising through debt or equity?

As of the latest update on May 11, 2026, Medi Assist Healthcare Services Limited reported that the group became debt-free in January 2026. There is no mention of any current or planned fundraising through debt or equity in the provided document. The company focuses on growing organically and via acquisitions like Paramount but does not indicate plans for raising capital through debt or equity. Free cash flow position is strong at INR 260.5 crores, and net worth is INR 852.4 crores, supporting financial stability without immediate need for external fundraising. No disclosures or guidance relate

Any current/future capex/capital investment/strategic investment?

The transcript does not explicitly mention any specific current or planned capex or capital investments. The company is focused on technology development, particularly AI and SaaS platforms, which are implied investments in tech capabilities. There is significant emphasis on integration of acquisitions (e.g., Paramount) over 4-5 quarters, which may involve some strategic investments related to operational scaling. Expansion into international markets like Southeast Asia and Thailand suggests potential strategic investments in those regions. Continued partnerships and integrations with governme

Future growth expectations in sales/revenue/volumes?

Core group business organic growth currently tracking at 8%-10% (same-store growth). Historical post-COVID same-store growth peaked at 20%-25%, now moderating. Growth rates influenced by IT-ITES slowdown; other industries like oil & gas, chemical, manufacturing showing promising life growth. Technology SaaS platform revenue grew 91.9% YoY, contributing 2.5% of total revenue, expected to scale further. International business pipeline built; markets like Southeast Asia targeted for expansion. Expected technology business to achieve 1.5x to 2x higher margin than traditional TPA business. Paramoun

Future growth expectations in earnings/operating earnings/profits/EPS?

Medi Assist expects continued growth driven by core TPA business, technology SaaS platform, international business, and new acquisitions (e.g., Paramount). Technology business currently contributes 2.5% of revenue but is growing rapidly (~91.9% YoY) with potential for higher-margin outcome-based pricing in future. International business pipeline is strong, especially in Southeast Asia; limited exposure to Middle East conflict. EBITDA margin improved steadily, reaching 19.9% in Q4 FY26; operating EBITDA grew 13.3% YoY. Adjusted PAT stood at INR 68.8 crores for FY26 after exceptional items. Orga

IN US

Sale is live|00:00:00left today

Medi Assist Healthcare Services LtdQ1 FY26Insurance

Medi Assist Healthcare Services Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹364P/E: 29.9Market Cap: ₹2.9K CrSector: Insurance

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Core group business organic growth currently tracking at 8%-10% (same-store growth).
→Historical post-COVID same-store growth peaked at 20%-25%, now moderating.
→Growth rates influenced by IT-ITES slowdown; other industries like oil & gas, chemical, manufacturing showing promising life growth.
→Technology SaaS platform revenue grew 91.9% YoY, contributing 2.5% of total revenue, expected to scale further.
→International business pipeline built; markets like Southeast Asia targeted for expansion.
→Expected technology business to achieve 1.5x to 2x higher margin than traditional TPA business.
→Paramount acquisition integration expected to complete in 1-2 quarters, improving margins.
→Government business growing strongly (42.6% YoY), with increasing public health engagement.
→Long-term vision aligned with government initiatives aiming for insurance coverage growth toward 2047.
→EBITDA margin expansion seen; Q4 margin at 19.9%.

Margin guidance

Category 3

→Medi Assist expects continued growth driven by core TPA business, technology SaaS platform, international business, and new acquisitions (e.g., Paramount).
→Technology business currently contributes 2.5% of revenue but is growing rapidly (~91.9% YoY) with potential for higher-margin outcome-based pricing in future.
→International business pipeline is strong, especially in Southeast Asia; limited exposure to Middle East conflict.
→EBITDA margin improved steadily, reaching 19.9% in Q4 FY26; operating EBITDA grew 13.3% YoY.
→Adjusted PAT stood at INR 68.8 crores for FY26 after exceptional items.
→Organic group business expected to grow at 8-10% on blended same-store growth despite IT-ITES sector slowdown, supported by diversified industry clientele.
→Margin expansion and revenue growth anticipated over next 1-2 quarters from Paramount integration.
→Long-term growth supported by increasing health insurance penetration and government digital initiatives.

3 more insights locked — sign up free to unlock

Fundraise plans

→As of the latest update on May 11, 2026, Medi Assist Healthcare Services Limited reported that the group became debt-free in January 2026.
→There is no mention of any current or planned fundraising through debt or equity in the provided document.
→The company focuses on growing organically and via acquisitions like Paramount but does not indicate plans for raising capital through debt or equity.
→Free cash flow position is strong at INR 260.5 crores, and net worth is INR 852.4 crores, supporting financial stability without immediate need for external fundraising.
→No disclosures or guidance related to future fundraising activities were provided during the conference or in the financial highlights.

Order book

Yes

→As per the transcript, Medi Assist Healthcare Services Limited disclosed a contract liability of INR 280.2 crores as of March 31, 2026.
→This contract liability represents revenue that is committed but has not yet been recognized in the Profit & Loss statement.
→The contract liability can be understood as the current order book or pending revenue from signed contracts that will be recognized in future periods.
→The company indicated that a significant portion of revenue is recognized on a 12-month service basis, contributing to this contract liability.
→There is no explicit disclosure of new pending orders beyond this contract liability figure in the transcript.

Capex plans

Yes

→The transcript does not explicitly mention any specific current or planned capex or capital investments.
→The company is focused on technology development, particularly AI and SaaS platforms, which are implied investments in tech capabilities.
→There is significant emphasis on integration of acquisitions (e.g., Paramount) over 4-5 quarters, which may involve some strategic investments related to operational scaling.
→Expansion into international markets like Southeast Asia and Thailand suggests potential strategic investments in those regions.
→Continued partnerships and integrations with government digital health platforms (e.g., National Health Claims Exchange) imply ongoing investment in technology infrastructure.
→No specific figures or detailed plans related to capex or strategic investments are disclosed on the provided pages.

How does Medi Assist Healthcare Services Ltd rank vs peers in Insurance?

Pro feature

1Medi Assist Healthcare Services Ltd

Rev 3Mar 3

See full Insurance sector rankings

Want more stocks like Medi Assist Healthcare Services Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio